bioRxiv: "Evaluation of the safety, immunogenicity and effi…" - Qoto Mastodon

bioRxiv @biorxivpreprint@qoto.org

Evaluation of the safety, immunogenicity and efficacy of a new live-attenuated lumpy skin disease vaccine in India https://www.biorxiv.org/content/10.1101/2022.12.10.519851v1?med=mas

Dec 11, 2022, 04:17 · · bioRxiv preprints · · ·

Sign in to participate in the conversation